Eka Ginanjar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eka Ginanjar has a total of 214 co-authors. Here are the top co-authors by number of shared publications:
Idrus Alwi
Indonesian Society of Internal Medicine
7 shared publicationsLies Dina Liastuti
Univ Indonesia, Dept Cardiol & Vasc Med, Fac Med, Jakarta, Indonesia
5 shared publications- Sally Aman Nasution
Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Special Capital Region of Jakarta.
5 shared publications Adik Wibowo
3 shared publications- Alvina Widhani
Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Diponegoro No. 71 Jakarta, Jakarta, 10430, Indonesia, 62 622-1390-4546
3 shared publications - Anshari Saifuddin Hasibuan
Ciptomangunkusumo General Hospital, Jakarta, Indonesia
3 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (7) , 889
Characterization of Spent Coffee Grounds’ Polyphenol Fraction and Its Potential as a Low-Cost Tool for Bioactivity-Guided Nephroprotective Modulation of Gut–Kidney Axis and NF-κB/Nrf2/TGF-β Signaling in Hypertension-Associated Kidney Injury
Background: Hypertension-associated kidney injury is driven by oxidative stress, inflammation, fibrosis, and gut-derived uremic toxins via the gut–kidney axis. Spent coffee grounds (SCG) represent a sustainable source of bioactive polyphenols with potential nephroprotective effects. This study aimed to characterize a bioactivity-guided SCG polyphenol fraction and evaluate its therapeutic potential. Methods: Bioactivity-guided fractionation was performed to enrich active polyphenols, followed by in silico target prediction and in vivo validation using L-NAME-induced hypertensive rats treated for 8 weeks. Renal function, oxidative stress, inflammatory and fibrotic markers, gut-derived metabolites, and endothelial function were assessed. Results: The enriched fraction was dominated by chlorogenic acid derivatives and showed predicted interactions with NF-κB, Keap1/Nrf2, TGF-β receptor, ACE, and AT1 receptor. In hypertensive rats, treatment significantly lowered blood pressure, improved renal function, reduced oxidative stress, inflammation, fibrosis, and gut-derived uremic toxins, while restoring Nrf2 activity, short-chain fatty acid production, and endothelial function. Across multiple biological endpoints, the polyphenol-enriched fraction consistently demonstrated greater efficacy than the crude extract. Conclusions: SCG polyphenol fraction shows strong nephroprotective potential via gut–kidney axis modulation and NF-κB/Nrf2/TGF-β regulation, supporting its development as a low-cost therapeutic candidate.
- 17 July 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (7) , 889
Open AccessCharacterization of Spent Coffee Grounds’ Polyphenol Fraction and Its Potential as a Low-Cost Tool for Bioactivity-Guided Nephroprotective Modulation of Gut–Kidney Axis and NF-κB/Nrf2/TGF-β Signaling in Hypertension-Associated Kidney Injury
Background: Hypertension-associated kidney injury is driven by oxidative stress, inflammation, fibrosis, and gut-derived uremic toxins via the gut–kidney axis. Spent coffee grounds (SCG) represent a sustainable source of bioactive polyphenols with potential nephroprotective effects. This study aimed to characterize a bioactivity-guided SCG polyphenol fraction and evaluate its therapeutic potential. Methods: Bioactivity-guided fractionation was performed to enrich active polyphenols, followed by in silico target prediction and in vivo validation using L-NAME-induced hypertensive rats treated for 8 weeks. Renal function, oxidative stress, inflammatory and fibrotic markers, gut-derived metabolites, and endothelial function were assessed. Results: The enriched fraction was dominated by chlorogenic acid derivatives and showed predicted interactions with NF-κB, Keap1/Nrf2, TGF-β receptor, ACE, and AT1 receptor. In hypertensive rats, treatment significantly lowered blood pressure, improved renal function, reduced oxidative stress, inflammation, fibrosis, and gut-derived uremic toxins, while restoring Nrf2 activity, short-chain fatty acid production, and endothelial function. Across multiple biological endpoints, the polyphenol-enriched fraction consistently demonstrated greater efficacy than the crude extract. Conclusions: SCG polyphenol fraction shows strong nephroprotective potential via gut–kidney axis modulation and NF-κB/Nrf2/TGF-β regulation, supporting its development as a low-cost therapeutic candidate.
- 1 April 2026
- Vol. 58 (2) , 174-192
Socio-Demographic Characteristics, Income, and Lifestyle of Internists Across Indonesia: A National Cross-Sectional Survey.
Internal medicine specialists have always been one of the pillars that support the health of Indonesian people. Currently, there is no available survey regarding the socio-demography, lifestyle, and income of any medical specialist in Indonesia. This study aims to report this gap in knowledge amongst internists across Indonesia. This study was a nationwide cross-sectional study and was conducted via online questionnaires by The Indonesian Society of Internal Medicine Specialists (INASIM) between December 2023 and March 2024. Participants from the existing 39 INASIM branches were selected using cluster random sampling, with a target of 20% of registered internists per branch. Of 1,568 internists invited, 1,082 (69.0%) completed the questionnaire and were included. A total of 1,082 internists participated in this study, mostly male (57.7%), aged 35-49 years (57.7%), non-academic staff (64.3%), practicing as general internists (76.3%) in 3 locations (70.9%). Distribution discrepancy was observed with 58.0% of general internists and 71.5% of subspecialists practicing in urban areas only. Income analyses showed significant positive correlations with age, working years, working hours, and number of practices. Male internists had higher income than their counterparts, indicating a gender-related income gap. The location of practice did not affect income significantly. Amongst internists, there were approximately 11.1% with a history of smoking, 55.9% with daily coffee consumption, 62.9% with sleep deprivation, and more time spent being sedentary. This study identified distribution discrepancy, a gender-related income gap, and unhealthy lifestyle patterns among Indonesian internists, which are issues that warrant targeted policy responses. Nevertheless, these findings may support future policies on equitable workforce distribution, appropriate incentive systems, and physician wellness programs in Indonesia.
- 1 April 2026
- Vol. 58 (2) , 174-192
Socio-Demographic Characteristics, Income, and Lifestyle of Internists Across Indonesia: A National Cross-Sectional Survey.
Internal medicine specialists have always been one of the pillars that support the health of Indonesian people. Currently, there is no available survey regarding the socio-demography, lifestyle, and income of any medical specialist in Indonesia. This study aims to report this gap in knowledge amongst internists across Indonesia. This study was a nationwide cross-sectional study and was conducted via online questionnaires by The Indonesian Society of Internal Medicine Specialists (INASIM) between December 2023 and March 2024. Participants from the existing 39 INASIM branches were selected using cluster random sampling, with a target of 20% of registered internists per branch. Of 1,568 internists invited, 1,082 (69.0%) completed the questionnaire and were included. A total of 1,082 internists participated in this study, mostly male (57.7%), aged 35-49 years (57.7%), non-academic staff (64.3%), practicing as general internists (76.3%) in 3 locations (70.9%). Distribution discrepancy was observed with 58.0% of general internists and 71.5% of subspecialists practicing in urban areas only. Income analyses showed significant positive correlations with age, working years, working hours, and number of practices. Male internists had higher income than their counterparts, indicating a gender-related income gap. The location of practice did not affect income significantly. Amongst internists, there were approximately 11.1% with a history of smoking, 55.9% with daily coffee consumption, 62.9% with sleep deprivation, and more time spent being sedentary. This study identified distribution discrepancy, a gender-related income gap, and unhealthy lifestyle patterns among Indonesian internists, which are issues that warrant targeted policy responses. Nevertheless, these findings may support future policies on equitable workforce distribution, appropriate incentive systems, and physician wellness programs in Indonesia.
- 1 April 2026
- Vol. 58 (2) , 253-263
Effect of Listening to Quran Recitation on the Quality of Life of Systemic Lupus Erythematosus Patients: A Quasi-Experimental Study.
Quality of life (QoL) is not sufficiently considered in current systemic lupus erythematosus (SLE) treatment targets, even though it's significantly impaired. Studies have shown that higher religiousness is associated with a higher QoL. This study aimed to determine the effect of listening to Quran recitations on the QoL of SLE patients. A quasi-experimental study with a pretest-posttest study design was conducted at Cipto Mangunkusumo Hospital, Jakarta. Participants were females aged 18 years or older with SLE, Muslim, and not experiencing hearing loss. Those who didn't regularly listen to the Quran were assigned to the control group. The intervention group consisted of patients who had previously listened to the Quran on a more regular basis, as well as those who had not. The intervention group listened to a Quran (QS. Ar-Rahman) for a minimum duration of 15 minutes, twice daily, for 40 days. A comparison of the effects of listening to the Quran within the group was conducted using a paired T-test, with a Wilcoxon test applied when necessary. p-values of less than 0.05 were considered statistically significant. A total of 65 participants were included in the study, with 32 in the intervention group and 33 in the control group. The results indicated a significant increase in QoL in the intervention group (p=0.023). Additionally, there was a reduction in anxiety levels within the intervention group (p=0.030). Listening to Quran recitation can enhance QoL, while also decreasing anxiety in patients with SLE.
- 1 April 2026
- Vol. 58 (2) , 253-263
Effect of Listening to Quran Recitation on the Quality of Life of Systemic Lupus Erythematosus Patients: A Quasi-Experimental Study.
Quality of life (QoL) is not sufficiently considered in current systemic lupus erythematosus (SLE) treatment targets, even though it's significantly impaired. Studies have shown that higher religiousness is associated with a higher QoL. This study aimed to determine the effect of listening to Quran recitations on the QoL of SLE patients. A quasi-experimental study with a pretest-posttest study design was conducted at Cipto Mangunkusumo Hospital, Jakarta. Participants were females aged 18 years or older with SLE, Muslim, and not experiencing hearing loss. Those who didn't regularly listen to the Quran were assigned to the control group. The intervention group consisted of patients who had previously listened to the Quran on a more regular basis, as well as those who had not. The intervention group listened to a Quran (QS. Ar-Rahman) for a minimum duration of 15 minutes, twice daily, for 40 days. A comparison of the effects of listening to the Quran within the group was conducted using a paired T-test, with a Wilcoxon test applied when necessary. p-values of less than 0.05 were considered statistically significant. A total of 65 participants were included in the study, with 32 in the intervention group and 33 in the control group. The results indicated a significant increase in QoL in the intervention group (p=0.023). Additionally, there was a reduction in anxiety levels within the intervention group (p=0.030). Listening to Quran recitation can enhance QoL, while also decreasing anxiety in patients with SLE.
- Open Access
- 13 January 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1707551
Cardiovascular-kidney-metabolic syndrome in Indonesia: a commentary on the need for integrated management and policy action
Cardiovascular-kidney-metabolic (CKM) syndrome is a term introduced to reflect the multidirectional relationship between metabolic disorders, kidney disease, and cardiovascular disease (CVD). The prevalence of CKM syndrome, accompanied by its increasing morbidity and mortality, has led researchers, clinicians, and policymakers to undertake synergistic and collaborative efforts in various countries. CKM Syndrome can be categorized into four stages: stage 0 (no risk factors), stage 1 (excessive or dysfunctional adiposity), stage 2 (metabolic risk factors or moderate to high-risk chronic kidney disease/CKD), stage 3 (subclinical cardiovascular disease or CKM syndrome risk equivalents), and stage 4 (clinical CVD in CKM). As the late stage in CKM syndrome, CVD become the leading cause of mortality in Indonesia, accounting for 37–38% of all deaths, with stroke and ischemic heart disease being the predominant causes. Over time, Indonesia has also seen an increase in the prevalence of other illnesses that contribute to the development of CKM syndrome, such as obesity, diabetes mellitus, CKD, hypertension, and dyslipidemia. Rapid urbanization, lifestyle changes, and demographic transitions have amplified the risk of CKM-related conditions. This perspective highlights the emerging risk factors for CKM syndrome in Indonesia, including diabetes mellitus and metabolic syndrome, CKD, and hypertension. This study relies on secondary data from national surveys, government policy reports, and scientific studies related to CKM syndrome. Data were selected based on relevance to CVD, kidney disease, as well as metabolic disorders. Furthermore, we discuss how these factors put a disproportionate burden on the Indonesian health system and should be looked up as a unified clinical as well as public health challenges, rather than separate entities. Addressing CKM syndrome in Indonesia requires early detection in primary care, integration and collaboration programs, as well as multi-sectoral approaches to reduce the progression of CKM syndrome. The lessons from Indonesia may provide insight for other low middle-income countries (LMICs) undergoing similar conditions.
- 13 January 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1707551
Open AccessCardiovascular-kidney-metabolic syndrome in Indonesia: a commentary on the need for integrated management and policy action
Cardiovascular-kidney-metabolic (CKM) syndrome is a term introduced to reflect the multidirectional relationship between metabolic disorders, kidney disease, and cardiovascular disease (CVD). The prevalence of CKM syndrome, accompanied by its increasing morbidity and mortality, has led researchers, clinicians, and policymakers to undertake synergistic and collaborative efforts in various countries. CKM Syndrome can be categorized into four stages: stage 0 (no risk factors), stage 1 (excessive or dysfunctional adiposity), stage 2 (metabolic risk factors or moderate to high-risk chronic kidney disease/CKD), stage 3 (subclinical cardiovascular disease or CKM syndrome risk equivalents), and stage 4 (clinical CVD in CKM). As the late stage in CKM syndrome, CVD become the leading cause of mortality in Indonesia, accounting for 37–38% of all deaths, with stroke and ischemic heart disease being the predominant causes. Over time, Indonesia has also seen an increase in the prevalence of other illnesses that contribute to the development of CKM syndrome, such as obesity, diabetes mellitus, CKD, hypertension, and dyslipidemia. Rapid urbanization, lifestyle changes, and demographic transitions have amplified the risk of CKM-related conditions. This perspective highlights the emerging risk factors for CKM syndrome in Indonesia, including diabetes mellitus and metabolic syndrome, CKD, and hypertension. This study relies on secondary data from national surveys, government policy reports, and scientific studies related to CKM syndrome. Data were selected based on relevance to CVD, kidney disease, as well as metabolic disorders. Furthermore, we discuss how these factors put a disproportionate burden on the Indonesian health system and should be looked up as a unified clinical as well as public health challenges, rather than separate entities. Addressing CKM syndrome in Indonesia requires early detection in primary care, integration and collaboration programs, as well as multi-sectoral approaches to reduce the progression of CKM syndrome. The lessons from Indonesia may provide insight for other low middle-income countries (LMICs) undergoing similar conditions.
- Open Access
- 26 November 2025
- Published by Elsevier in JACC: Asia
- Vol. 6 (4) , 510-520
Cardiometabolic Risk Among Internal Medicine Specialists in Indonesia (CARMEINA)
- 26 November 2025
- Published by Elsevier in JACC: Asia
- Vol. 6 (4) , 510-520
Open AccessCardiometabolic Risk Among Internal Medicine Specialists in Indonesia (CARMEINA)
- 1 October 2025
- Vol. 57 (4) , 552-558
Benefit of Influenza Vaccination in Patients with Cardiovascular Disease.
Influenza remains a significant global health problem. The risks of complication and death from influenza are greater in comorbid groups, such as those suffering cardiovascular diseases. The true economic and social costs of influenza are far greater in these groups compared to healthy ones as these groups are vulnerable to complications and even death. Cardiovascular disease is the leading cause of death, both globally and in Indonesia. The relationship between cardiovascular events and seasonal influenza has been established. Influenza vaccination is one of the prevention methods that has proven effective in preventing influenza infection and reducing the risk of major cardiovascular events. In addition to being effective, influenza vaccination is also safe and well-tolerated by adults and the elderly. This review outlines the impacts of influenza and the benefits of influenza vaccine in groups with cardiovascular disease.
- 1 October 2025
- Vol. 57 (4) , 552-558
Benefit of Influenza Vaccination in Patients with Cardiovascular Disease.
Influenza remains a significant global health problem. The risks of complication and death from influenza are greater in comorbid groups, such as those suffering cardiovascular diseases. The true economic and social costs of influenza are far greater in these groups compared to healthy ones as these groups are vulnerable to complications and even death. Cardiovascular disease is the leading cause of death, both globally and in Indonesia. The relationship between cardiovascular events and seasonal influenza has been established. Influenza vaccination is one of the prevention methods that has proven effective in preventing influenza infection and reducing the risk of major cardiovascular events. In addition to being effective, influenza vaccination is also safe and well-tolerated by adults and the elderly. This review outlines the impacts of influenza and the benefits of influenza vaccine in groups with cardiovascular disease.
- 1 October 2025
- Vol. 57 (4) , 485-492
The Role of Probiotics in Depression and Quality of Life in Patients with Irritable Bowel Syndrome.
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder frequently accompanied by psychological disturbances such as depression and reduced quality of life. Probiotic intervention has been studied as a potential adjunct therapy to address psychological symptoms and improve the quality of life in IBS patients. This study aims to evaluate the effect of probiotic supplementation on depressive symptoms and quality of life in IBS patients at Dr. Cipto Mangunkusumo National General Hospital using the Beck Depression Inventory-II (BDI-II) and SF-36 instruments. This study was a double-blind randomized controlled trial with a pre-post intervention design. A total of 70 participants were randomly assigned into two groups: the intervention group (n=35), which received probiotics, and the control group (n=35), which received a placebo. Depressive symptoms were assessed using the BDI-II, while quality of life was measured using the SF-36 questionnaire, both before and after the intervention. Statistical analysis was performed using the Mann-Whitney test and independent t-test, with a significance level of p<0.05. After the intervention, the probiotic group showed a significant reduction in BDI-II scores compared to the placebo group (p<0.0001). In addition, the probiotic group demonstrated significant improvements in almost all domains of the SF-36 compared to the placebo group, including physical functioning, role physical, bodily pain, general health, vitality, social functioning, emotional well-being, and mental health (p<0.0001). Probiotic supplementation significantly reduces depressive symptoms and improves quality of life in IBS patients. These findings support the potential of probiotics as an adjunct therapy in the comprehensive management of IBS.
- 1 October 2025
- Vol. 57 (4) , 485-492
The Role of Probiotics in Depression and Quality of Life in Patients with Irritable Bowel Syndrome.
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder frequently accompanied by psychological disturbances such as depression and reduced quality of life. Probiotic intervention has been studied as a potential adjunct therapy to address psychological symptoms and improve the quality of life in IBS patients. This study aims to evaluate the effect of probiotic supplementation on depressive symptoms and quality of life in IBS patients at Dr. Cipto Mangunkusumo National General Hospital using the Beck Depression Inventory-II (BDI-II) and SF-36 instruments. This study was a double-blind randomized controlled trial with a pre-post intervention design. A total of 70 participants were randomly assigned into two groups: the intervention group (n=35), which received probiotics, and the control group (n=35), which received a placebo. Depressive symptoms were assessed using the BDI-II, while quality of life was measured using the SF-36 questionnaire, both before and after the intervention. Statistical analysis was performed using the Mann-Whitney test and independent t-test, with a significance level of p<0.05. After the intervention, the probiotic group showed a significant reduction in BDI-II scores compared to the placebo group (p<0.0001). In addition, the probiotic group demonstrated significant improvements in almost all domains of the SF-36 compared to the placebo group, including physical functioning, role physical, bodily pain, general health, vitality, social functioning, emotional well-being, and mental health (p<0.0001). Probiotic supplementation significantly reduces depressive symptoms and improves quality of life in IBS patients. These findings support the potential of probiotics as an adjunct therapy in the comprehensive management of IBS.
- 1 July 2025
- Vol. 57 (3) , 396-402
The Use of Secretome and Exosomes in Cardiovascular Diseases.
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Recent advancements in regenerative medicine have unveiled the promising roles of secretome and exosomes in the treatment of CVDs. In this article, we aim to understand the roles of secretome and exosomes in the cardiovascular system, both in physiological and pathological conditions, and explore the broad applications of secretome and exosomes in mitigating CVD progression. Secretome and exosomes, which play crucial roles in intercellular communication, tissue repair, and immunomodulation, have shown potential in reducing cardiovascular disease progression by inhibiting inflammation, promoting blood vessel growth, and regulating biological mechanisms. Further research is needed to maximize their use in advanced cardiovascular therapy.
- 1 July 2025
- Vol. 57 (3) , 396-402
The Use of Secretome and Exosomes in Cardiovascular Diseases.
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Recent advancements in regenerative medicine have unveiled the promising roles of secretome and exosomes in the treatment of CVDs. In this article, we aim to understand the roles of secretome and exosomes in the cardiovascular system, both in physiological and pathological conditions, and explore the broad applications of secretome and exosomes in mitigating CVD progression. Secretome and exosomes, which play crucial roles in intercellular communication, tissue repair, and immunomodulation, have shown potential in reducing cardiovascular disease progression by inhibiting inflammation, promoting blood vessel growth, and regulating biological mechanisms. Further research is needed to maximize their use in advanced cardiovascular therapy.
- 1 April 2025
- Vol. 57 (2) , 200-211
Diagnostic Performance of INA-FRAIL and Study of Osteoporotic Fractures (SOF) Index Compared to Cardiovascular Health Study (CHS) in Diagnosing Frailty Syndrome in Older Adults with Heart Failure.
There is currently no gold standard for assessing frailty syndrome in older adults with heart failure. The Cardiovascular Health Study (CHS) is a reference standard for evaluating frailty in older adults with heart failure. Still, it requires a dynamometer and a spacious space, rendering it impractical in daily practice. The INA-FRAIL and Study of Osteoporotic Fractures (SOF) Index can often be easy to use; however, it has not been evaluated for diagnostic performance on older adults with heart failure in Indonesia. This study aimed to assess the diagnostic performance of INA-FRAIL and SOF-Index in diagnosing frailty in older adults with heart failure. This cross-sectional study evaluated the diagnostic performances of INA-FRAIL and SOF-Index compared to CHS as the gold standard in this study. The population was heart failure patients aged > 60 at Cipto Mangunkusumo Hospital. Analysis from 81 samples shows the prevalence of frailty based on CHS (35.5%), INA-FRAIL (23.5%), and SOF-Index (8,6%). Diagnostic performance analysis of INA-FRAIL showed a sensitivity of 55,17% (95% CI 35.69-73.55), specificity 94.23% (95% CI 84.05- 98.79), and AUC 0.805 (95% CI 0.698-0.912). Diagnostic performance analysis of SOF showed 20,69% sensitivity (95% CI 7.99 - 39.72), 98.08% specificity (95% CI 89.74 - 99.95), and AUC 0.719 (95% CI 0.595 - 0.843). INA-FRAIL and SOF-Index had a significant association with CHS. The cut-off point of INA-FRAIL ≥1 showed the highest sensitivity, while INA-FRAIL ≥2 showed the highest Youden index. The cut-off point of SOF ≥1 showed the highest sensitivity and the highest Youden index.
- 1 April 2025
- Vol. 57 (2) , 200-211
Diagnostic Performance of INA-FRAIL and Study of Osteoporotic Fractures (SOF) Index Compared to Cardiovascular Health Study (CHS) in Diagnosing Frailty Syndrome in Older Adults with Heart Failure.
There is currently no gold standard for assessing frailty syndrome in older adults with heart failure. The Cardiovascular Health Study (CHS) is a reference standard for evaluating frailty in older adults with heart failure. Still, it requires a dynamometer and a spacious space, rendering it impractical in daily practice. The INA-FRAIL and Study of Osteoporotic Fractures (SOF) Index can often be easy to use; however, it has not been evaluated for diagnostic performance on older adults with heart failure in Indonesia. This study aimed to assess the diagnostic performance of INA-FRAIL and SOF-Index in diagnosing frailty in older adults with heart failure. This cross-sectional study evaluated the diagnostic performances of INA-FRAIL and SOF-Index compared to CHS as the gold standard in this study. The population was heart failure patients aged > 60 at Cipto Mangunkusumo Hospital. Analysis from 81 samples shows the prevalence of frailty based on CHS (35.5%), INA-FRAIL (23.5%), and SOF-Index (8,6%). Diagnostic performance analysis of INA-FRAIL showed a sensitivity of 55,17% (95% CI 35.69-73.55), specificity 94.23% (95% CI 84.05- 98.79), and AUC 0.805 (95% CI 0.698-0.912). Diagnostic performance analysis of SOF showed 20,69% sensitivity (95% CI 7.99 - 39.72), 98.08% specificity (95% CI 89.74 - 99.95), and AUC 0.719 (95% CI 0.595 - 0.843). INA-FRAIL and SOF-Index had a significant association with CHS. The cut-off point of INA-FRAIL ≥1 showed the highest sensitivity, while INA-FRAIL ≥2 showed the highest Youden index. The cut-off point of SOF ≥1 showed the highest sensitivity and the highest Youden index.
- 1 January 2024
- Vol. 56 (1) , 46-54
Impacts of the COVID-19 Pandemic on the CODE ST-Segment Elevation Myocardial Infarction Program: A Quantitative and Qualitative Analysis
Background: The code ST-segment elevation myocardial infarction (STEMI) program is an operational standard of integrated service for STEMI patients carried out by Dr. Cipto Mangunkusumo Hospital. The emerging coronavirus disease 2019 (COVID-19) outbreak brought about many changes in the management of healthcare services, including the code STEMI program. This study aimed to evaluate the healthcare service quality of the Code STEMI program during the COVID-19 pandemic based on the Donabedian concept. Methods: This was a mixed-methods study using quantitative and qualitative analyses. It was conducted at the Dr. Cipto Mangunkusumo Hospital, a national referral hospital in Indonesia. We compared the data of each patient, including response time, clinical outcomes, length of stay, and cost, from two years between 2018-2020 and 2020-2022 as the pre-COVID-19 code STEMI and COVID-19 Code STEMI periods, respectively. Interviews were conducted to determine the quality of services from the perspectives of stakeholders. Results: A total of 195 patients participated in the study: 120 patients in pre-COVID-19 code STEMI and 75 patients in COVID-19 code STEMI. Our results showed that there was a significant increase in patient's length of stay during the COVID-19 pandemic (4 days vs. 6 days, p < 0.001). Meanwhile, MACE (13% vs. 11%, p = 0.581), the in-hospital mortality rate (8% vs. 5%, p = 0.706), door-to-wire crossing time (161 min vs. 173 min, p = 0.065), door-to-needle time (151 min vs. 143 min p = 0.953), and hospitalization cost (3,490 USD vs. 3,700 USD, p = 0.945) showed no significant changes. In terms of patient satisfaction, patients found code STEMI during COVID-19 to be responsive and excellent. Conclusion: The implementation of the code STEMI program during the COVID-19 pandemic revealed that modified pathways were required because of the COVID-19 screening process. According to the Donabedian model, during the pandemic, the code STEMI program's healthcare service quality decreased because of a reduction in efficacy, effectiveness, efficiency, and optimality. Despite these limitations attributed to the pandemic, the code STEMI program was able to provide good services for STEMI patients.
- 1 January 2024
- Vol. 56 (1) , 46-54
Impacts of the COVID-19 Pandemic on the CODE ST-Segment Elevation Myocardial Infarction Program: A Quantitative and Qualitative Analysis
Background: The code ST-segment elevation myocardial infarction (STEMI) program is an operational standard of integrated service for STEMI patients carried out by Dr. Cipto Mangunkusumo Hospital. The emerging coronavirus disease 2019 (COVID-19) outbreak brought about many changes in the management of healthcare services, including the code STEMI program. This study aimed to evaluate the healthcare service quality of the Code STEMI program during the COVID-19 pandemic based on the Donabedian concept. Methods: This was a mixed-methods study using quantitative and qualitative analyses. It was conducted at the Dr. Cipto Mangunkusumo Hospital, a national referral hospital in Indonesia. We compared the data of each patient, including response time, clinical outcomes, length of stay, and cost, from two years between 2018-2020 and 2020-2022 as the pre-COVID-19 code STEMI and COVID-19 Code STEMI periods, respectively. Interviews were conducted to determine the quality of services from the perspectives of stakeholders. Results: A total of 195 patients participated in the study: 120 patients in pre-COVID-19 code STEMI and 75 patients in COVID-19 code STEMI. Our results showed that there was a significant increase in patient's length of stay during the COVID-19 pandemic (4 days vs. 6 days, p < 0.001). Meanwhile, MACE (13% vs. 11%, p = 0.581), the in-hospital mortality rate (8% vs. 5%, p = 0.706), door-to-wire crossing time (161 min vs. 173 min, p = 0.065), door-to-needle time (151 min vs. 143 min p = 0.953), and hospitalization cost (3,490 USD vs. 3,700 USD, p = 0.945) showed no significant changes. In terms of patient satisfaction, patients found code STEMI during COVID-19 to be responsive and excellent. Conclusion: The implementation of the code STEMI program during the COVID-19 pandemic revealed that modified pathways were required because of the COVID-19 screening process. According to the Donabedian model, during the pandemic, the code STEMI program's healthcare service quality decreased because of a reduction in efficacy, effectiveness, efficiency, and optimality. Despite these limitations attributed to the pandemic, the code STEMI program was able to provide good services for STEMI patients.